Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes

被引:64
作者
Hill, Deirdre A.
Wang, Sophia S.
Cerhan, James R.
Davis, Scott
Cozen, Wendy
Severson, Richard K.
Hartge, Patricia
Wacholder, Sholom
Yeager, Meredith
Chanock, Stephen J.
Rothman, Nathaniel
机构
[1] Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Sch Med, Ctr Canc, Albuquerque, NM 87131 USA
[3] DHHS, Div Canc Epidemiol & Genet, NCI, NIH, Bethesda, MD USA
[4] Univ Iowa, Iowa City, IA USA
[5] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA
[6] Univ Washington, Seattle, WA 98195 USA
[7] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[8] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA
[9] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[10] Wayne State Univ, Dept Family Med, Detroit, MI USA
[11] DHHS, Core Genotyping Facil, Adv Technol Corp, NCI,NIH, Gaithersburg, MD USA
关键词
D O I
10.1182/blood-2005-01-026690
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chromosomal translocations, insertions, and deletions are common early events in non-Hodgkin lymphoma (NHL) carcinogenesis, and implicated in their formation are endogenous processes involved in antigen-receptor diversification, such as V(D)J recombination. DNA repair genes respond to the double- and single-strand breaks induced by these processes and may influence NHL etiology. We examined 34 genetic variants in 19 genes within or related to 5 DNA repair pathways among 1172 cases and 982 matched controls who participated in a population-based NHL study in Los Angeles, Seattle, Detroit, and Iowa from 1998 to 2000. Cases were more likely than controls to have the RAG1 820 R/R (odds ratio [OR] = 2.7; 95% confidence interval [CI] = 1.4 to 5.0) than Lys/Lys genotypes, with evidence of a gene dosage effect (P trend <.001), and less likely to have the LIG4 (DNA ligase IV) 9 Ile/Ile (OR = 0.5; 95% Cl = 0.3 to 0.9) than TIT genotype (P trend =.03) in the nonhomologous end joining (NHEJ)/V(D)J pathway. These NHEJ/V(D)J-related gene variants represent promising candidates for further studies of NHL etiology and require replication in other studies.
引用
收藏
页码:3161 / 3167
页数:7
相关论文
共 43 条
[1]   EVIDENCE OF AN ASSOCIATION BETWEEN NON-HODGKINS-LYMPHOMA AND SKIN-CANCER [J].
ADAMI, J ;
FRISCH, M ;
YUEN, J ;
GLIMELIUS, B ;
MELBYE, M .
BRITISH MEDICAL JOURNAL, 1995, 310 (6993) :1491-1495
[2]   Repair of U/G and U/A in DNA by UNG2-associated repair complexes takes place predominantly by short-patch repair both in proliferating and growth-arrested cells [J].
Akbari, M ;
Otterlei, M ;
Peña-Diaz, J ;
Aas, PA ;
Kavli, B ;
Liabakk, NB ;
Hagen, L ;
Imai, K ;
Durandy, A ;
Slupphaug, G ;
Krokan, HE .
NUCLEIC ACIDS RESEARCH, 2004, 32 (18) :5486-5498
[3]  
AUERBACH AD, 1998, GENETIC BASIS HUMAN, P317
[4]   BRCA2 Arg372His polymorphism and epithelial ovarian cancer risk [J].
Auranen, A ;
Spurdle, AB ;
Chen, XQ ;
Lipscombe, J ;
Purdie, DM ;
Hopper, JL ;
Green, A ;
Healey, CS ;
Redman, K ;
Dunning, AM ;
Pharoah, PD ;
Easton, DF ;
Ponder, BAJ ;
Chenevix-Trench, G ;
Novik, KL .
INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (03) :427-430
[5]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[6]  
Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310
[7]  
Chatterjee N, 2004, CANCER EPIDEM BIOMAR, V13, P1415
[8]   Problems of reporting genetic associations with complex outcomes [J].
Colhoun, HM ;
McKeigue, PM ;
Smith, GD .
LANCET, 2003, 361 (9360) :865-872
[9]   Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome [J].
Corneo, B ;
Moshous, D ;
Güngör, T ;
Wulffraat, N ;
Philippet, P ;
Le Deist, F ;
Fischer, A ;
de Villartay, JP .
BLOOD, 2001, 97 (09) :2772-2776
[10]   No association between BRCA2 N372H and breast cancer risk [J].
Cox, DG ;
Hankinson, SE ;
Hunter, DJ .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (05) :1353-1354